Condition
Retinitis Pigmentosa (RP) clinical trials and research
As of November 12, 2026, Find a Trial lists 11 Retinitis Pigmentosa (RP) clinical trials that are recruiting, at sites in 10 countries (most in United States (3), France (2), Egypt (1)). 1 was first registered in the last 30 days. By phase: Phase 1/2 (3), Phase 2/3 (1), Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11Clinical trials
- 1New in 30 days
- 10Countries
Newest Retinitis Pigmentosa (RP) clinical trials
All recruiting trials (11)
-
Eye gene therapy for retinitis pigmentosa with a single RTx-015 injection
A single eye injection of RTx-015 is being tested to see if it helps people with retinitis pigmentosa.
-
Gene therapy SPVN20 for advanced rod-cone dystrophy
This study tests different doses of SPVN20 injected into the eye to see if it is safe and can help people with advanced rod-cone dystrophy.
-
Pitavastatin in PLGA Nanoparticles for Retinitis Pigmentosa safety test
This Phase 1 study tests whether an intravenous pitavastatin nanoparticle formulation is safe for adults with retinitis pigmentosa.
-
NPI-001 for preserving photoreceptors in RP with Usher syndrome
This trial tests whether NPI-001 can slow vision loss in adults with RP linked to Usher syndrome, compared with a placebo over 24 months.
-
Short-term effects of transcorneal electrical stimulation on visual performance
This study will see if a 30-minute session of transcorneal electrical stimulation with the OkuStim device produces short-term vision improvements in adults with retinitis pigmentosa or similar retinal degenerations who already use the device.
-
Brain stimulation to improve orientation and mobility in adults with vision impairment
This pilot test checks if a non-invasive brain stimulation method can help people with constricted visual fields move around more easily using a cane and other cues.
-
Early nurse and psychological support after a new retinitis pigmentosa diagnosis
This program will test whether early nurse follow-up and a psychologist visit for adults newly diagnosed with retinitis pigmentosa improve patient satisfaction and reduce anxiety and depression.
-
Restoring central vision with the PRIMA implant for photoreceptor degeneration
This trial will test whether a small PRIMA implant can restore limited central vision in adults with inherited photoreceptor degeneration such as Stargardt disease or retinitis pigmentosa.
-
Using a capsular tension ring to keep the lens implant centered in people with retinitis pigmentosa who need cataract surgery
This trial will try adding a capsular tension ring to one eye of adults with retinitis pigmentosa undergoing cataract surgery to see if it keeps the implanted lens more centered and reduces vision problems compared with the other eye.
-
Investigating OpCT-001 for treating primary photoreceptor disease
This study is testing a new treatment called OpCT-001 to see if it can safely help adults with primary photoreceptor diseases, like Retinitis Pigmentosa and Usher Syndrome, improve their vision.
-
New peptide therapy for retinal diseases
This study is testing a new peptide therapy to see if it can help adults with retinal diseases like age-related macular degeneration and diabetic retinopathy improve their vision and eye health.
Related topics
Quick answers
How many Retinitis Pigmentosa (RP) clinical trials are recruiting right now?
11, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in United States (3 trials), France (2 trials), Egypt (1 trial), China (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 3, Phase 2/3: 1, Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.